Viewing StudyNCT03864042



Ignite Creation Date: 2024-05-06 @ 12:51 PM
Last Modification Date: 2024-10-26 @ 1:05 PM
Study NCT ID: NCT03864042
Status: COMPLETED
Last Update Posted: 2023-06-08
First Post: 2019-02-01

Brief Title: Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors
Sponsor: Pfizer
Organization: Pfizer

Conditions & Keywords Data

Conditions:
Name
Metastatic Melanoma
Advanced Solid Tumors
Keywords:
Name View
melanoma View
solid tumor View